Marucci Gabriella, Angeli Piero, Buccioni Michela, Gulini Ugo, Melchiorre Carlo, Sagratini Gianni, Testa Rodolfo, Giardinà Dario
Department of Chemical Sciences, University of Camerino, Italy.
Eur J Pharmacol. 2005 Oct 17;522(1-3):100-7. doi: 10.1016/j.ejphar.2005.08.044. Epub 2005 Oct 6.
To shed light on the discrepancy between reported binding and functional affinity and selectivity at alpha(1b/B)-adrenoceptors, the antagonist (+)-cyclazosin was reinvestigated in rat and rabbit tissues. It displayed a competitive antagonism at alpha(1A) and alpha(1D)-adrenoceptors of rat prostatic vas deferens and aorta with pA(2) values 7.75 and 7.27, respectively. In rabbit thoracic aorta (+)-cyclazosin competitively antagonized noradrenaline-induced contractions at alpha(1B)-adrenoceptors with a pA(2) value of 8.85, whereas its affinity at alpha(1L)-adrenoceptors was markedly lower (pA(2) = 6.75-7.09). In conclusion, these data confirmed that (+)-cyclazosin is a selective alpha(1B)-adrenoceptor antagonist also in functional assays, showing 13- and 38-fold selectivity for the alpha(1B)-adrenoceptor over alpha(1A)- and alpha(1D)-subtypes, respectively. Furthermore, (+)-cyclazosin displayed a significant selectivity for alpha(1B)-adrenoceptors relative to the alpha(1L)-subtype.
为了阐明在α(1b/B) -肾上腺素能受体上报道的结合亲和力与功能亲和力及选择性之间的差异,我们在大鼠和兔组织中对拮抗剂(+) -环唑嗪进行了重新研究。它在大鼠前列腺输精管和主动脉的α(1A)和α(1D) -肾上腺素能受体上表现出竞争性拮抗作用,其pA(2)值分别为7.75和7.27。在兔胸主动脉中,(+) -环唑嗪在α(1B) -肾上腺素能受体上竞争性拮抗去甲肾上腺素诱导的收缩,pA(2)值为8.85,而其在α(1L) -肾上腺素能受体上的亲和力明显较低(pA(2) = 6.75 - 7.09)。总之,这些数据证实,在功能测定中(+) -环唑嗪也是一种选择性α(1B) -肾上腺素能受体拮抗剂,对α(1B) -肾上腺素能受体相对于α(1A) -和α(1D) -亚型的选择性分别为13倍和38倍。此外,(+) -环唑嗪相对于α(1L) -亚型对α(1B) -肾上腺素能受体表现出显著的选择性。